Agilon Health, Inc.
AGL · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6,060,530 | $4,316,363 | $2,388,220 | $1,521,494 |
| % Growth | 40.4% | 80.7% | 57% | – |
| Cost of Goods Sold | $6,055,689 | $4,246,693 | $2,276,860 | $1,455,750 |
| Gross Profit | $4,841 | $69,670 | $111,360 | $65,744 |
| % Margin | 0.1% | 1.6% | 4.7% | 4.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $268,912 | $285,760 | $207,789 | $427,502 |
| SG&A Expenses | $268,912 | $285,760 | $207,789 | $427,502 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $28,059 | $16,043 | $8,949 | $10,484 |
| Operating Expenses | $296,971 | $301,803 | $216,738 | $437,986 |
| Operating Income | -$292,130 | -$232,133 | -$105,378 | -$372,242 |
| % Margin | -4.8% | -5.4% | -4.4% | -24.5% |
| Other Income/Exp. Net | $43,304 | $37,671 | $14,708 | -$10,734 |
| Pre-Tax Income | -$248,826 | -$194,462 | -$90,670 | -$382,976 |
| Tax Expense | $1,451 | $791 | $1,640 | $886 |
| Net Income | -$260,151 | -$262,596 | -$106,553 | -$406,487 |
| % Margin | -4.3% | -6.1% | -4.5% | -26.7% |
| EPS | -0.63 | -0.64 | -0.26 | -1.09 |
| % Growth | 1.6% | -146.2% | 76.1% | – |
| EPS Diluted | -0.63 | -0.64 | -0.26 | -1.09 |
| Weighted Avg Shares Out | 410,966 | 408,917 | 408,154 | 372,931 |
| Weighted Avg Shares Out Dil | 410,966 | 408,917 | 408,154 | 372,931 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6,177 | $6,658 | $4,484 | $6,146 |
| Depreciation & Amortization | $24,463 | $20,161 | $13,772 | $14,670 |
| EBITDA | -$218,186 | -$167,643 | -$72,414 | -$362,160 |
| % Margin | -3.6% | -3.9% | -3% | -23.8% |